| 000 | 01632 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517044940.0 | ||
| 264 | 0 | _c20160908 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a1095-8584 | ||
| 024 | 7 |
_a10.1016/j.yjmcc.2015.07.028 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLilyanna, Shera | |
| 245 | 0 | 0 |
_aGYY4137 attenuates remodeling, preserves cardiac function and modulates the natriuretic peptide response to ischemia. _h[electronic resource] |
| 260 |
_bJournal of molecular and cellular cardiology _cOct 2015 |
||
| 300 |
_a27-37 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAtrial Natriuretic Factor _xmetabolism |
| 650 | 0 | 4 |
_aCardiotonic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrogen Sulfide _xmetabolism |
| 650 | 0 | 4 |
_aIschemia _xdrug therapy |
| 650 | 0 | 4 |
_aMorpholines _xadministration & dosage |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aNatriuretic Peptide, Brain _xmetabolism |
| 650 | 0 | 4 |
_aOrganothiophosphorus Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aVentricular Dysfunction, Left _xdrug therapy |
| 650 | 0 | 4 |
_aVentricular Remodeling _xdrug effects |
| 700 | 1 | _aPeh, Meng Teng | |
| 700 | 1 | _aLiew, Oi Wah | |
| 700 | 1 | _aWang, Peipei | |
| 700 | 1 | _aMoore, Philip K | |
| 700 | 1 | _aRichards, Arthur Mark | |
| 700 | 1 | _aMartinez, Eliana C | |
| 773 | 0 |
_tJournal of molecular and cellular cardiology _gvol. 87 _gp. 27-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.yjmcc.2015.07.028 _zAvailable from publisher's website |
| 999 |
_c25150698 _d25150698 |
||